The Vanguard Group, Inc.
The role involves handling life sciences patent disputes, including Hatch‑Waxman (ANDA) and Biologics (BPCIA) litigation, representing innovator pharmaceutical companies in district court and before the PTAB. Candidates should be highly motivated, detail‑oriented, and possess substantial experience in this specialized IP area.
Headquarters
Valley Forge, Pennsylvania, United States
Company Size
10001+ employees
Founded
1975
N/A
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for The Vanguard Group, Inc..
The Vanguard Group, Inc. didn’t post a salary, so this is our estimate from similar listings.
23% below the average for this role
Vanguard (NYSE: CME) reports 36.25M shares, cites 01/12/2026 realignment
1 week ago
Intellectual Property Litigation Associate
Db_b875d025731feea5a308bba40eb6e1b7
IP Litigation Associate
Db_b875d025731feea5a308bba40eb6e1b7
IP Litigation Associate
Db_b875d025731feea5a308bba40eb6e1b7
Pharmaceutical Patent Litigation – Mid-Level Associate
Hogan Lovells
IP Litigation Counsel
Samsung US
Junior/Mid-Level IP Pharmaceutical Litigation Attorney
lewisassociates